Bausch Health Companies Inc. (BHC) Stock Forecast
BHC analyst forecast
as of October 17, 2026- Analyst consensus
- Hold 3.00 / 5 from 7 analysts
- Price target
- $7.50 average of analyst targets
- Upside to target
- +19.0% from the latest close
- Next earnings
- October 28, 2026 EPS estimate $1.08
- 52-week range
- $4.43 – $7.90
BHC analyst ratings
7 analystsNumber of analysts at each rating.
BHC price target
The average of analyst 12-month price targets compared with the latest close and the 52-week range.
BHC earnings per share estimates
| Period | Average | Low | High | Year ago | Growth | Analysts |
|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | $1.24 | $1.12 | $1.38 | $1.16 | +6.8% | 6 |
| Current fiscal year (2026) | $4.52 | $4.32 | $4.76 | $3.75 | +20.7% | 6 |
| Next fiscal year (2027) | $4.29 | $4.05 | $4.79 | $4.52 | −5.0% | 6 |
Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.
BHC revenue estimates
| Period | Average | Low | High | Growth | Analysts |
|---|---|---|---|---|---|
| Current quarter (Sep '26) | $2.75B | $2.73B | $2.79B | +2.8% | 4 |
| Current fiscal year (2026) | $10.92B | $10.92B | $10.94B | +6.4% | 5 |
| Next fiscal year (2027) | $10.94B | $10.88B | $11.05B | +0.1% | 5 |
BHC EPS: reported and forecast
Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.
BHC revenue: reported and forecast
BHC EPS estimate revisions
| Period | 90 days ago | 60 days ago | 30 days ago | 7 days ago | Now | Change (90 d) | Revisions (30 d) |
|---|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | $1.28 | $1.19 | $1.19 | $1.22 | $1.24 | −3.0% | 1 up · 0 down |
| Current fiscal year (2026) | $4.42 | $4.47 | $4.47 | $4.47 | $4.52 | +2.3% | 1 up · 0 down |
| Next fiscal year (2027) | $4.22 | $4.19 | $4.19 | $4.19 | $4.29 | +1.8% | 0 up · 1 down |
How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.
BHC earnings surprises
Reported EPS vs the consensus estimate for the last 12 quarters; BHC beat in 8 of 12.
What analysts expect from BHC
7 analysts cover Bausch Health; their consensus rating is hold (3.00 on a 1–5 scale, where 5 is a strong buy). The average price target is $7.50, 19.0% above the latest close of $6.30. Analysts expect earnings of $4.52 per share for 2026, +20.7% from a year earlier. For 2027 the average estimate is $4.29 per share on revenue of $10.9 billion. Bausch Health beat the EPS estimate in 8 of the last 12 quarters.
Related: BHC income statement, BHC key metrics, BHC chart. See the BHC stock overview for the latest quote and news.
BHC forecast FAQ
What is Bausch Health's price target?
The average analyst price target for Bausch Health is $7.50, 19.0% above the latest close of $6.30.
Is Bausch Health a buy, hold or sell?
Of 7 analysts covering Bausch Health, 0 rate it a strong buy, 0 a buy, 7 a hold, 0 a sell and 0 a strong sell, a consensus of hold. Ratings are opinions, not a recommendation from Quotelinks.
What is Bausch Health's EPS forecast?
Analysts forecast $4.52 per share for 2026 (range $4.32 to $4.76); for 2027 the estimate is $4.29.
What is Bausch Health's revenue forecast?
The average revenue estimate for 2026 is $10.9 billion, growth of 6.4%; for 2027 it is $10.9 billion.
When does Bausch Health report earnings?
Bausch Health is expected to report results for the quarter ending September 30, 2026 on October 28, 2026 after the market closes; the EPS estimate is $1.08.
Does Bausch Health usually beat earnings estimates?
Bausch Health reported EPS at or above the analyst estimate in 8 of the last 12 quarters.